Nevro Corp. (NVRO)

$51.89

+2.04 (+4.09%)
Rating:
Recommendation:
Buy
Symbol NVRO
Price $51.89
Beta 0.964
Volume Avg. 0.51M
Market Cap 1.909B
Shares () -
52 Week Range 39.41-127.969
1y Target Est -
DCF Unlevered NVRO DCF ->
DCF Levered NVRO LDCF ->
ROE -51.05% Strong Sell
ROA -26.63% Sell
Operating Margin -
Debt / Equity 127.80% Buy
P/E -
P/B 7.97 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest NVRO news


Mr. D.Keith Grossman
Healthcare
Medical Devices
New York Stock Exchange

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.